Simplex Trading, LLC Cytosorbents Corp Transaction History

Simplex Trading, LLC

$175 Billion
Q2 2025

A detailed history of Simplex Trading, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 100 shares of CTSO stock, worth $70. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Holding current value

$70

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$0.81 - $1.28 $81 - $128	100 New	100 $0
Q4 2024 Feb 11, 2025	BUY	$0.74 - $1.35 $231 - $422	313 New	313 $0
Q2 2024 Jul 25, 2024	SELL	$0.7 - $1.01 $420 - $606	-600 Reduced 96.77%	20 $0
Q1 2024 Apr 25, 2024	SELL	$0.86 - $1.07 $721 - $897	-839 Reduced 57.51%	620 $0
Q4 2023 Feb 02, 2024	BUY	$1.08 - $1.94 $314 - $564	291 Added 24.91%	1,459 $1,000
Q3 2023 Nov 01, 2023	SELL	$1.86 - $4.03 $47,268 - $102,414	-25,413 Reduced 95.61%	1,168 $2,000
Q2 2023 Aug 04, 2023	BUY	$2.37 - $3.65 $4,818 - $7,420	2,033 Added 8.28%	26,581 $95,000
Q1 2023 Apr 27, 2023	BUY	$1.79 - $4.17 $42,367 - $98,699	23,669 Added 2692.72%	24,548 $82,000
Q4 2022 Feb 02, 2023	BUY	$1.03 - $2.03 $625 - $1,232	607 Added 223.16%	879 $1,000
Q3 2022 Nov 04, 2022	SELL	$1.2 - $2.46 $211 - $432	-176 Reduced 39.29%	272 $0
Q2 2022 Aug 03, 2022	SELL	$1.76 - $3.22 $13,867 - $25,370	-7,879 Reduced 94.62%	448 $0
Q1 2022 May 02, 2022	BUY	$2.88 - $4.23 $16,845 - $24,741	5,849 Added 236.04%	8,327 $26,000
Q4 2021 Feb 23, 2022	SELL	$4.05 - $8.11 $49,729 - $99,582	-12,279 Reduced 83.21%	2,478 $10,000
Q3 2021 Oct 28, 2021	BUY	$7.0 - $9.71 $5,642 - $7,826	806 Added 5.78%	14,757 $111,000
Q2 2021 Aug 12, 2021	BUY	$7.55 - $9.42 $105,330 - $131,418	13,951 New	13,951 $105,000
Q4 2020 Feb 02, 2021	SELL	$7.65 - $8.98 $24,135 - $28,331	-3,155 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$7.37 - $11.54 $67,597 - $105,844	-9,172 Reduced 74.41%	3,155 $25,000
Q2 2020 Jul 13, 2020	BUY	$6.28 - $10.59 $77,413 - $130,542	12,327 New	12,327 $122,000
Q1 2020 Apr 29, 2020	SELL	$3.77 - $7.73 $4,124 - $8,456	-1,094 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$3.61 - $5.22 $786 - $1,137	218 Added 24.89%	1,094 $4,000
Q3 2019 Oct 15, 2019	SELL	$4.33 - $7.63 $7,343 - $12,940	-1,696 Reduced 65.94%	876 $4,000
Q2 2019 Jul 26, 2019	BUY	$5.92 - $7.78 $6,855 - $9,009	1,158 Added 81.9%	2,572 $17,000
Q1 2019 Apr 18, 2019	BUY	$6.82 - $8.56 $7,883 - $9,895	1,156 Added 448.06%	1,414 $0
Q4 2018 Jan 16, 2019	SELL	$7.05 - $12.64 $80,602 - $144,513	-11,433 Reduced 97.79%	258 $2,000
Q3 2018 Oct 23, 2018	SELL	$10.95 - $14.8 $24,024 - $32,471	-2,194 Reduced 15.8%	11,691 $150,000
Q2 2018 Jul 30, 2018	BUY	$6.9 - $12.35 $95,806 - $171,479	13,885 New	13,885 $158,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.4M

Call Options Held

28.9K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $30.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account